← All updates
Observational study

Endocrinology · General Practice ·

Medicare Diabetes Prevention Program Participants Report High Satisfaction

A qualitative study explored experiences of 25 Medicare beneficiaries enrolled in or recently completing the Medicare Diabetes Prevention Program. Participants valued its group format, lifestyle coaches and practical curriculum, and reported changes in diet, activity and self-reported health.

The Medicare Diabetes Prevention Program (MDPP), covered by the Centers for Medicare & Medicaid Services since 2018, is based on the CDC-recognized National Diabetes Prevention Program. Researchers recruited beneficiaries through nine MDPP suppliers and held 10 virtual focus groups from March to May 2023. The 25 participants were enrolled in or had recently completed the program as of February 2023; transcripts were analyzed using rapid qualitative methods.

Participants most commonly said they enrolled to prevent diabetes and lose weight. They reported high satisfaction, citing the group-based format, support from lifestyle coaches and practical guidance on diet and physical activity. Participants also described improvements in these behaviors and in self-reported health outcomes, including hemoglobin A1c levels.

The findings describe participants’ perceptions rather than independently measured or controlled changes in health outcomes. The small, selected sample of people who enrolled in the program limits conclusions about its effectiveness or the experiences of beneficiaries who did not participate. The study was funded through a CMS contract to RTI International, and the authors reported no competing interests.

In practice

For clinicians discussing diabetes prevention with Medicare beneficiaries, this study suggests that participants who enroll in the MDPP value its group format, coaching and practical lifestyle curriculum. However, the study involved only 25 current or recent participants recruited through nine suppliers, and reported health changes, including HbA1c, were self-reported. It did not measure program effectiveness against a comparator or establish that the program caused clinical improvements, so these findings do not support changing treatment or prevention recommendations.

AI-generated clinical interpretation · Not editor-reviewed

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Sign in to rate this summary →

Source

BMC Public Health: Beneficiary experiences in the Medicare Diabetes Prevention Program: a qualitative focus group study ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.